The importance of loss functions: A note on the evolution of the Toxicity Probability Interval design
The Toxicity Probability Interval Design by Ji et al. (2007), which was subsequently modified by the mTPI (Ji et al., 2010), proposed a more efficient approach to early-phase dose-finding than conventional designs like 3 + 3. Subsequent authors reported issues with the method, finding that it tends...
Main Author: | Jonathan Siegel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865420301782 |
Similar Items
-
Statistical Similarity Analysis Based on Neutrosophic Interval Probability
by: Jiaming Song, et al.
Published: (2021-10-01) -
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
by: Taketo Suzuki, et al.
Published: (2019-02-01) -
Advancements in the radiooncological treatment of high-risk prostate cancer: a quarter century of achievements
by: Moll Matthias, et al.
Published: (2022-08-01) -
Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)
by: Abrahim Al-Mamgani, et al.
Published: (2023-11-01) -
Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre
by: Vincent Khoo, et al.
Published: (2011-09-01)